Shilpa Medicare Ltd. (SHILPAMED) Share Price Near 52-Week High as Stock Trades at Rs 978
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Shilpa Medicare Share Price is trading at Rs 978, up 2.15% from the previous close, and is positioned near its 52-week high as of 18 September 2026 at 10:18 AM IST. The company’s market capitalisation stands at Rs 18,143.15 crore, putting the move in a clear market-cap context for Shilpa Medicare Share Price Today. The latest Univest figures confirm the stock is being tracked closely in Shilpa Medicare Stock News and Shilpa Medicare Share News, but the price event itself does not establish a company-specific catalyst. What the market data does show is a stock that has advanced to within a narrow band of its yearly high while remaining in active focus for Shilpa Medicare Share Price Live searches and broader Indian Stock Market screens.
Shilpa Medicare Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 978 |
| Previous Close | Rs 957.4 |
| Today's Move | +Rs 20.6 (+2.15%) |
| Open | Rs 959.4 |
| High | Rs 984.55 |
| Low | Rs 952.85 |
| Turnover | Rs 1.66 crore |
| Market Capitalisation | Rs 18,143.15 crore |
Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 978 versus the previous close of Rs 957.4, a rise of 2.15%. The stock opened at Rs 959.4, reached a high of Rs 984.55 and touched a low of Rs 952.85.
Shilpa Medicare Share Price Today moved from a previous close of Rs 957.4 to Rs 978, a gain of Rs 20.6 or 2.15%. The stock opened at Rs 959.4, touched an intraday high of Rs 984.55 and a low of Rs 952.85, while turnover stood at Rs 1.66 crore. Measured against the 52-week high event, the current price is only 1.32% below the Rs 991.1 yearly high, keeping Shilpa Medicare Share Price in the near-peak zone that many market screens flag as 52 Week High Stocks. For Shilpa Medicare Share Price Today, the key fact is simple: the stock is trading close to its one-year high, but the latest Univest data does not establish a company-specific reason for the move. That makes the next read-through a fundamental one.
Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,143.15 crore |
| P/E Ratio | 62.98x |
| P/B Ratio | 6.97x |
| ROE | 9.82% |
| ROCE | 11.43% |
| EPS | Rs 15.2 |
| Book Value Per Share | Rs 137.34 |
| Dividend Yield | 0.06% |
Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 62.98x, P/B 6.97x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.
Shilpa Medicare Ltd. has a market capitalisation of Rs 18143.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.98x, P/B at 6.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 62.98x |
| Benchmark Median P/E | 28.19x |
| Benchmark Average P/E | 37.43x |
| Benchmark P/E Range | 0x to 417.17x |
| Company P/B Ratio | 6.97x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 9.82% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 11.43% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 18,143.15 crore |
| Benchmark Median Market Cap | Rs 733.35 crore |
Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 62.98x, which is above the benchmark median of 28.19x, a difference of +123.41%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.78%, a difference of -16.64%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.65%, a difference of -16.26%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Eris Lifesciences Ltd. | ERIS | 18,090.66 | 28.19 | 4.5 | 19.23 | 14.47 |
| ONESOURCE SPECL PHARMA L | ONESOURCE | 18,331.03 | 0 | 3.1 | -1.26 | 0.44 |
| Pfizer Ltd. | PFIZER | 18,359.71 | 24.99 | 4.17 | 17.16 | 23.39 |
| Glenmark Life Sciences Ltd. | ALIVUS | 17,029.01 | 28.24 | 4.89 | 18.41 | 24.61 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 19,639.14 | 29.65 | 5.37 | 20.79 | 24.97 |
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 62.98x compared with the displayed peer median of 28.19x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.82% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 23.39%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 18,143.15 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare
- Shilpa Medicare Share Price is at Rs 978 and remains 1.32% below the Rs 991.1 52-week high.
- The stock is up Rs 20.6, or 2.15%, from the previous close of Rs 957.4.
- Market capitalisation is Rs 18,143.15 crore, which places Shilpa Medicare Share Price in a clearly defined size bracket.
- P/E of 62.98 and P/B of 6.97 are both above the same-industry median benchmarks.
- Revenue and net profit for the stated periods have increased, with Jun 2026 revenue at Rs 4,657.8 crore and net profit at Rs 1,008.8 crore.
About Shilpa Medicare
Shilpa Medicare Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Shilpa Medicare Share Price is therefore watched as part of the broader healthcare universe on the NSE and BSE. The latest Univest coverage places the company within a valuation and financial-results frame that includes market capitalisation, revenue, earnings, book value, EPS and return ratios. For readers following Shilpa Medicare Share Price Today, the company’s current market profile is best read through those figures rather than through assumptions about future business conditions.
Frequently Asked Questions
Why is Shilpa Medicare Share Price near its 52-week high?
Ans. Shilpa Medicare Share Price is at Rs 978, which is 1.32% below the Rs 991.1 52-week high. The latest Univest figures confirm the near-peak price event, but they do not establish a specific company catalyst.
What is Shilpa Medicare Share Price Today?
Ans. Shilpa Medicare Share Price Today is Rs 978, compared with the previous close of Rs 957.4. That leaves the stock higher by Rs 20.6, or 2.15%, in the latest session window.
What does Shilpa Medicare Stock News show today?
Ans. Shilpa Medicare Stock News today centres on the near 52-week high event and the current valuation profile. The market cap is Rs 18,143.15 crore, and the P/E ratio stands at 62.98.
How expensive is Shilpa Medicare Share Price versus the industry?
Ans. Shilpa Medicare Share Price trades at a P/E of 62.98 and a P/B of 6.97, both above the same-industry medians of 28.19 and 3.08. The valuation premium is visible in the benchmark comparison.
What are the key fundamental numbers for Shilpa Medicare?
Ans. Shilpa Medicare Fundamental Analysis includes EPS of Rs 15.2, book value of Rs 137.34, dividend yield of 0.06%, ROE of 9.82 and ROCE of 11.43. Revenue and net profit also rose in the stated periods.
How does Shilpa Medicare compare with healthcare peers?
Ans. Compared with peers such as Eris Lifesciences, Pfizer, Glenmark Life Sciences and Caplin Point Laboratories, Shilpa Medicare has a higher P/E and P/B but lower ROE and ROCE in the supplied set.
What is the market capitalisation of Shilpa Medicare?
Ans. Shilpa Medicare Market Cap is Rs 18,143.15 crore. That places the company above the same-industry median market cap of Rs 733.35 crore and close to the peer group’s market-cap band.
Should investors track Shilpa Medicare Share Price on Univest?
Ans. Yes, readers tracking Shilpa Medicare Share Price on Univest can follow live price updates, financial ratios, 52-week levels, sector context and peer comparisons together. It keeps Shilpa Medicare Share Price in one searchable view.
Track Shilpa Medicare Share Price on Univest
Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Shilpa Medicare Share Price on Univest to follow live share price updates, 52-week levels, valuation ratios, financial results, sector context and peer comparisons in one place. Univest also helps readers review Shilpa Medicare Stock News, Shilpa Medicare Latest News and Shilpa Medicare Share Price Live updates with a clear market-data view.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
